CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 22.0
(-0.18%)
EUR 22.0
(-0.18%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 741.08 Million EUR | 1.08% |
| 2022 | 733.16 Million EUR | 17.19% |
| 2021 | 625.62 Million EUR | 25.58% |
| 2020 | 498.19 Million EUR | 9.99% |
| 2019 | 452.94 Million EUR | 41.68% |
| 2018 | 319.68 Million EUR | -2.23% |
| 2017 | 326.97 Million EUR | -0.39% |
| 2016 | 328.23 Million EUR | 0.76% |
| 2015 | 325.76 Million EUR | -5.31% |
| 2014 | 344.03 Million EUR | 23.16% |
| 2013 | 279.34 Million EUR | 23.69% |
| 2012 | 225.84 Million EUR | -3.48% |
| 2011 | 233.99 Million EUR | 22.23% |
| 2010 | 191.43 Million EUR | 75.56% |
| 2009 | 109.03 Million EUR | 920.49% |
| 2008 | 10.68 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 743.48 Million EUR | 5.38% |
| 2024 Q1 | 742.8 Million EUR | 0.18% |
| 2023 Q2 | 664.26 Million EUR | 0.42% |
| 2023 Q1 | 661.51 Million EUR | -9.77% |
| 2023 FY | 741.08 Million EUR | 1.08% |
| 2023 Q4 | 741.08 Million EUR | 2.44% |
| 2023 Q3 | 723.4 Million EUR | 8.9% |
| 2022 Q1 | 566.93 Million EUR | -9.38% |
| 2022 Q3 | 775.89 Million EUR | 16.27% |
| 2022 Q2 | 667.31 Million EUR | 17.71% |
| 2022 FY | 733.16 Million EUR | 17.19% |
| 2022 Q4 | 733.16 Million EUR | -5.51% |
| 2021 Q2 | 586.87 Million EUR | 28.11% |
| 2021 Q1 | 458.1 Million EUR | -8.05% |
| 2021 FY | 625.62 Million EUR | 25.58% |
| 2021 Q3 | 616.91 Million EUR | 5.12% |
| 2021 Q4 | 625.62 Million EUR | 1.41% |
| 2020 FY | 498.19 Million EUR | 9.99% |
| 2020 Q1 | 434.19 Million EUR | -4.14% |
| 2020 Q2 | 434.57 Million EUR | 0.09% |
| 2020 Q3 | 430.93 Million EUR | -0.84% |
| 2020 Q4 | 498.19 Million EUR | 15.61% |
| 2019 Q4 | 452.94 Million EUR | 24.01% |
| 2019 FY | 452.94 Million EUR | 41.68% |
| 2019 Q3 | 365.26 Million EUR | 6.54% |
| 2019 Q1 | 334.57 Million EUR | 4.66% |
| 2019 Q2 | 342.84 Million EUR | 2.47% |
| 2018 Q2 | 279.84 Million EUR | 1.08% |
| 2018 FY | 319.68 Million EUR | -2.23% |
| 2018 Q1 | 276.84 Million EUR | -15.33% |
| 2018 Q4 | 319.68 Million EUR | -0.04% |
| 2018 Q3 | 319.81 Million EUR | 14.28% |
| 2017 Q3 | 304.47 Million EUR | -1.63% |
| 2017 Q2 | 309.52 Million EUR | -1.85% |
| 2017 Q1 | 315.37 Million EUR | -3.92% |
| 2017 FY | 326.97 Million EUR | -0.39% |
| 2017 Q4 | 326.97 Million EUR | 7.39% |
| 2016 Q4 | 328.23 Million EUR | 6.88% |
| 2016 Q1 | 294.07 Million EUR | -9.73% |
| 2016 Q2 | 309.84 Million EUR | 5.36% |
| 2016 FY | 328.23 Million EUR | 0.76% |
| 2016 Q3 | 307.09 Million EUR | -0.89% |
| 2015 Q1 | 318.18 Million EUR | -7.51% |
| 2015 FY | 325.76 Million EUR | -5.31% |
| 2015 Q4 | 325.76 Million EUR | -3.11% |
| 2015 Q3 | 336.22 Million EUR | 0.08% |
| 2015 Q2 | 335.94 Million EUR | 5.58% |
| 2014 Q4 | 344.03 Million EUR | 4.31% |
| 2014 Q3 | 329.81 Million EUR | 17.97% |
| 2014 Q1 | 268.64 Million EUR | -3.83% |
| 2014 Q2 | 279.57 Million EUR | 4.07% |
| 2014 FY | 344.03 Million EUR | 23.16% |
| 2013 Q2 | 190.46 Million EUR | -5.52% |
| 2013 Q3 | 213.4 Million EUR | 12.04% |
| 2013 Q4 | 279.34 Million EUR | 30.9% |
| 2013 FY | 279.34 Million EUR | 23.69% |
| 2013 Q1 | 201.6 Million EUR | -10.74% |
| 2012 Q1 | 240.37 Million EUR | 2.73% |
| 2012 Q3 | 209.49 Million EUR | -4.61% |
| 2012 FY | 225.84 Million EUR | -3.48% |
| 2012 Q4 | 225.84 Million EUR | 7.8% |
| 2012 Q2 | 219.61 Million EUR | -8.64% |
| 2011 Q2 | 227.05 Million EUR | 0.3% |
| 2011 Q3 | 225.54 Million EUR | -0.66% |
| 2011 Q4 | 233.99 Million EUR | 3.75% |
| 2011 FY | 233.99 Million EUR | 22.23% |
| 2011 Q1 | 226.37 Million EUR | 18.25% |
| 2010 Q2 | 112.02 Million EUR | -2.85% |
| 2010 Q3 | 160.29 Million EUR | 43.09% |
| 2010 FY | 191.43 Million EUR | 75.56% |
| 2010 Q4 | 191.43 Million EUR | 19.42% |
| 2010 Q1 | 115.31 Million EUR | 5.75% |
| 2009 Q4 | 109.03 Million EUR | 0.0% |
| 2009 FY | 109.03 Million EUR | 920.49% |
| 2008 FY | 10.68 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| DocCheck AG | 4.95 Million EUR | -14851.187% |
| MeVis Medical Solutions AG | - EUR | -Infinity% |
| Nexus AG | 15.43 Million EUR | -4700.389% |